Utama › Limfoma Burkitt › West Virginia

Kajian klinikal Limfoma Burkitt di West Virginia

3 kajian untuk Limfoma Burkitt sedang mencari peserta di lokasi di West Virginia.

Teks kajian rasmi (Bahasa Inggeris)

Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia

West Virginia University Healthcare, Morgantown

Mengambil pesertaFasa 2

Umur 18 ke atas · Semua jantina · Dikemas kini 29 Sep 2026 · NCT03739814

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

West Virginia University Charleston Division, Charleston
West Virginia University Healthcare, Morgantown

Mengambil pesertaFasa 2

Umur 1 hingga 30 · Semua jantina · Dikemas kini 1 Sep 2026 · NCT04546399

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

West Virginia University Charleston Division, Charleston

Mengambil pesertaFasa 3

365 Days – 25 Years · Semua jantina · Dikemas kini 25 Ogo 2026 · NCT03959085

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.